Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D9421-C (Budesonide) in Japanese patients with active Crohn's disease
NCT00573469Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2006
- Primary completion
- Mar 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of budesonide in Crohn's disease, sponsored by AstraZeneca. Started Oct 2006; status: completed.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00573469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00573469.